EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

The European Journal of Radiology, published by Elsevier Ireland Ltd, is a premier peer-reviewed journal in the fields of radiology, nuclear medicine, and imaging. Established in 1981, it has carved a significant niche within the academic community, showcasing innovative research that enhances medical imaging practices and improves patient care. With an impressive ranking in the Q1 category for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging in 2023, the journal is recognized globally for its commitment to advancing scientific knowledge and improving imaging methodologies. The journal's Scopus ranking of #60/333, placing it in the 82nd percentile, underlines its reputation for high-quality research and scholarly contributions. While traditionally a subscription-based journal, it continually evolves to meet the demands of the academic landscape, aiming to bridge the gap between research and clinical practice. Researchers, healthcare professionals, and students alike can benefit from exploring its extensive archives and current publications, which are curated to foster education and innovation in the medical imaging domain.

Hong Kong Journal of Radiology, an esteemed publication of the Hong Kong Academy of Medicine Press, serves as a vital platform for disseminating innovative research in the field of radiology, nuclear medicine, and imaging. Established in 2011 and operating under an Open Access model since 2018, this journal not only promotes the sharing of knowledge but also enhances global accessibility to cutting-edge studies. With its ISSN 2223-6619 and E-ISSN 2307-4620, the journal strives to engage a diverse audience ranging from experienced professionals to aspiring scholars in the medical imaging domain. Despite its current ranking in the Q4 quartile of the Scopus category for radiology, the journal is committed to improving its standing by featuring high-quality research that addresses pressing issues in the field. The journal's convergence from 2011 to 2024 reflects its ongoing dedication to fostering academic excellence and encouraging collaborative discourse among researchers and practitioners globally. Located in Hong Kong, the journal plays a significant role in shaping the future of radiology education and practice in China and beyond.

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.